Lissa Pacheco-Brousseau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lissa Pacheco-Brousseau has a total of 92 co-authors. Here are the top co-authors by number of shared publications:
- Dawn Stacey
School of Nursing, University of Ottawa, Ottawa, Canada
8 shared publications - Stéphane Poitras
School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
7 shared publications - Marylène Charette
From the: Population Health, Interdisciplinary School of Health Sciences, Faculty of Health Sciences, University of Ottawa, Ottawa, Canada
3 shared publications - Paul Edgar Beaulé
Division of Orthopaedic Surgery, The Ottawa Hospital, Ottawa, Ontario, Canada
3 shared publications - Sarah Ben Amor
Telfer School of Management, University of Ottawa, Ottawa, Canada
3 shared publications Stéphane Poitras
School of Rehabilitation Sciences Faculty of Health Sciences University of Ottawa Ottawa Canada
3 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
Hip Preservation Surgery for Isolated Labral Tears in Patients with Femoral Acetabular Impingement and Dysplasia Provides Comparable Patient‐Reported Outcomes as Surgery but Slower Recovery and Higher Reoperation Rate for Dysplasia
Purpose: To assess clinical outcomes after hip preservation surgery for patients grouped into the 3 following conditions: dysplasia, femoroacetabular impingement (FAI), or isolated labral tears. Methods: Patients who underwent hip preservation surgery at our center between January 2018 and December 2021 were identified. Patients with dysplasia, FAI, or isolated labral tears were included. Clinical outcomes of the 3 condition groups were compared using the International Hip Outcome Tool‐12 and Patient‐Reported Outcomes Measurement Information System, which were collected preoperatively and at 3 months and 1 and 2 years postoperatively. Results: A total of 378 patients were included: 80 (22.4%) with dysplasia, 173 (48.6%) with FAI, and 103 (28.9%) with isolated labral tears. Arthroscopy (n = 269, 75.6%) was the most common procedure, followed by periacetabular osteotomy (n = 82, 23.0.4%) and surgical dislocation (n = 7, 2.0%). All groups had significant improvements in their International Hip Outcome Tool‐12 and Patient‐Reported Outcomes Measurement Information System physical ( P < .001). There were no significant differences between the 3 primary groups except with dysplasia at 3 months ( P = .018). The percentages of patients attaining minimal clinically important difference on the International Hip Outcome Tool‐12 at 1 year showed a significant difference between the 3 groups: 35.9% (FAI), 63.2% (dysplasia), and 48.6% (labral tears), P = .028. Reoperation rates, according to condition groups, were higher for dysplasia mainly because of the removal of internal fixation and similar between FAI and labral tear. Conclusions: In this study, we observed significant improvements in the patient‐reported outcome measures after hip preservation surgery for dysplasia, FAI, and isolated labral tears. Although dysplasia patients showed slower recovery and a higher reoperation rate, both the dysplasia and isolated labral tear groups were comparable in achieving minimal clinically important difference and substantial clinical benefit, whereas the FAI group had significantly lower percentages of patients achieving them. Level of Evidence: Level III, therapeutic retrospective comparative study.
- 15 November 2026
- Published by Wiley in Arthroscopy, Sports Medicine, and Rehabilitation
Open AccessHip Preservation Surgery for Isolated Labral Tears in Patients with Femoral Acetabular Impingement and Dysplasia Provides Comparable Patient‐Reported Outcomes as Surgery but Slower Recovery and Higher Reoperation Rate for Dysplasia
Purpose: To assess clinical outcomes after hip preservation surgery for patients grouped into the 3 following conditions: dysplasia, femoroacetabular impingement (FAI), or isolated labral tears. Methods: Patients who underwent hip preservation surgery at our center between January 2018 and December 2021 were identified. Patients with dysplasia, FAI, or isolated labral tears were included. Clinical outcomes of the 3 condition groups were compared using the International Hip Outcome Tool‐12 and Patient‐Reported Outcomes Measurement Information System, which were collected preoperatively and at 3 months and 1 and 2 years postoperatively. Results: A total of 378 patients were included: 80 (22.4%) with dysplasia, 173 (48.6%) with FAI, and 103 (28.9%) with isolated labral tears. Arthroscopy (n = 269, 75.6%) was the most common procedure, followed by periacetabular osteotomy (n = 82, 23.0.4%) and surgical dislocation (n = 7, 2.0%). All groups had significant improvements in their International Hip Outcome Tool‐12 and Patient‐Reported Outcomes Measurement Information System physical ( P < .001). There were no significant differences between the 3 primary groups except with dysplasia at 3 months ( P = .018). The percentages of patients attaining minimal clinically important difference on the International Hip Outcome Tool‐12 at 1 year showed a significant difference between the 3 groups: 35.9% (FAI), 63.2% (dysplasia), and 48.6% (labral tears), P = .028. Reoperation rates, according to condition groups, were higher for dysplasia mainly because of the removal of internal fixation and similar between FAI and labral tear. Conclusions: In this study, we observed significant improvements in the patient‐reported outcome measures after hip preservation surgery for dysplasia, FAI, and isolated labral tears. Although dysplasia patients showed slower recovery and a higher reoperation rate, both the dysplasia and isolated labral tear groups were comparable in achieving minimal clinically important difference and substantial clinical benefit, whereas the FAI group had significantly lower percentages of patients achieving them. Level of Evidence: Level III, therapeutic retrospective comparative study.
- 15 October 2026
- Published by The Journal of Rheumatology in The Journal of Rheumatology
Sex Differences in Clinical Need, Willingness, and Surgeon Recommendations for Total Knee Arthroplasty: A Cross-Sectional Study
Objective: Female individuals experience greater severity of knee osteoarthritis (OA) than their male counterparts but are disproportionately less likely to receive total knee arthroplasty (TKA). We examined whether sex differences in willingness to undergo TKA at surgeon consultation contributed to sex disparities. Methods: This cross-sectional study was nested in a prospective cohort of patients with knee OA referred to Alberta, Canada, hip/knee surgery clinics from 2014 to 2017. A preconsult questionnaire assessed TKA appropriateness and contextual factors. TKA willingness was defined as responding "yes" to "I would definitely consider having TKA now." Surgeons reported their TKA recommendation (yes/no) postconsultation. Multivariable logistic regression models examined the association of patient sex with TKA willingness (yes/no) and multivariable log Poisson regression models assessed the association of willingness with receipt of a surgeon recommendation for TKA, stratified by sex. Models were adjusted for TKA appropriateness (need, psychological readiness, expectations, health status) and contextual factors. Results: In total, 2035 participants were included (58.72% female; mean age 65.7 [SD 9.1] years). Adjusting for TKA appropriateness and contextual factors, the odds ratio associated with a female vs a male being "willing" was 0.67 (95% CI 0.51-0.88); 1518 (74.59%) participants were recommended TKA. The adjusted risk ratio associated with a "definitely willing" individual being recommended TKA was 5.03 (95% CI 3.04-8.33) in male and 2.15 (95% CI 1.68-2.75) in female individuals. Conclusion: Willingness to undergo TKA was associated with a higher likelihood of being recommended for TKA among male individuals than female individuals, raising concerns regarding bias.
- 15 October 2026
- Published by The Journal of Rheumatology in The Journal of Rheumatology
Sex Differences in Clinical Need, Willingness, and Surgeon Recommendations for Total Knee Arthroplasty: A Cross-Sectional Study
Objective: Female individuals experience greater severity of knee osteoarthritis (OA) than their male counterparts but are disproportionately less likely to receive total knee arthroplasty (TKA). We examined whether sex differences in willingness to undergo TKA at surgeon consultation contributed to sex disparities. Methods: This cross-sectional study was nested in a prospective cohort of patients with knee OA referred to Alberta, Canada, hip/knee surgery clinics from 2014 to 2017. A preconsult questionnaire assessed TKA appropriateness and contextual factors. TKA willingness was defined as responding "yes" to "I would definitely consider having TKA now." Surgeons reported their TKA recommendation (yes/no) postconsultation. Multivariable logistic regression models examined the association of patient sex with TKA willingness (yes/no) and multivariable log Poisson regression models assessed the association of willingness with receipt of a surgeon recommendation for TKA, stratified by sex. Models were adjusted for TKA appropriateness (need, psychological readiness, expectations, health status) and contextual factors. Results: In total, 2035 participants were included (58.72% female; mean age 65.7 [SD 9.1] years). Adjusting for TKA appropriateness and contextual factors, the odds ratio associated with a female vs a male being "willing" was 0.67 (95% CI 0.51-0.88); 1518 (74.59%) participants were recommended TKA. The adjusted risk ratio associated with a "definitely willing" individual being recommended TKA was 5.03 (95% CI 3.04-8.33) in male and 2.15 (95% CI 1.68-2.75) in female individuals. Conclusion: Willingness to undergo TKA was associated with a higher likelihood of being recommended for TKA among male individuals than female individuals, raising concerns regarding bias.
- 6 January 2026
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2026 (1) , CD015378
Total and partial knee arthroplasty versus non-surgical interventions of the knee for moderate to severe osteoarthritis
Rationale Total and partial knee arthroplasty (TKA, PKA) are common treatments for moderate to severe knee osteoarthritis. While effective in symptom management, these surgeries carry potential risks, necessitating careful evaluation of benefits and harms. High‐quality evidence comparing TKA/PKA to placebo, sham, or non‐surgical interventions is essential to support informed decision‐making. Objectives To assess the benefits and harms of TKA and PKA for people with moderate to severe knee osteoarthritis compared to placebo, sham (efficacy), or non‐surgical interventions for the knee (effectiveness). Search methods We searched CENTRAL, MEDLINE, Embase, and two trial registers from 2010 to January 2025. We also performed reference and citation checks. Two reviewers independently screened studies, extracted data, and assessed risk of bias and the certainty of evidence. Eligibility criteria We included randomised controlled trials of adults with moderate to severe osteoarthritis receiving TKA/PKA compared to placebo, sham, or non‐surgical treatments including physiotherapy, weight loss, pharmacotherapy, braces, insoles, and any intraarticular injection. We excluded studies including participants with other joint conditions or having TKA/PKA because of trauma (e.g. fracture), infection, or revision. Outcomes We reported on pain, physical function, knee surgery, patient satisfaction with treatment outcomes, health‐related quality of life, serious adverse events, and withdrawals due to adverse events. We measured outcomes at short‐term (≤ 6 months), intermediate‐term (6 to 12 months), and long‐term (≥ 1 year) follow‐up. Risk of bias We used the Cochrane RoB 1 tool to assess risk of bias. Synthesis methods We conducted a narrative synthesis, reported on risk ratios (RRs) for dichotomous data and mean differences (MDs) for continuous data with a 95% confidence interval (CI), and used GRADE to assess the certainty of evidence. Included studies One randomised controlled trial conducted in Denmark met the inclusion criteria. The study enrolled 100 adults with primary mild to severe knee osteoarthritis (Kellgren‐Lawrence score ≥ 2 to 4) and compared TKA followed by a non‐surgical programme (exercise, osteoarthritis education, dietary advice, insoles, pain medication) to the same non‐surgical programme alone. Synthesis of results Pain Compared to a non‐surgical programme, unilateral TKA may reduce pain at a level that is clinically important at one year (MD 17.60, 95% CI 8.25 to 26.95; 1 study, 100 participants; low‐certainty evidence). The certainty of evidence was low given the imprecision of results and risk of bias. Physical function Compared to a non‐surgical programme, unilateral TKA may improve physical function at one year, but the improvement might not be clinically important (MD 12.40, 95% CI 3.06 to 21.74; 1 study, 100 participants; low‐certainty evidence). The certainty of evidence was low given the imprecision of results and risk of bias. Knee surgery Compared to a non‐surgical programme, unilateral TKA may reduce the need for a follow‐up knee surgery (revision or subsequent knee surgery and initial knee surgery) at one year (RR 0.04, 95% CI 0.00 to 0.62; 1 study, 99 participants; low‐certainty evidence). The certainty of evidence was low given the imprecision of results and risk of bias. Patient satisfaction with treatment outcomes The included trial did not assess patient satisfaction with treatment outcomes. Health‐related quality of life There is probably no clinically important difference in health‐related quality of life between unilateral TKA and non‐surgical treatment at one year (MD 0.09, 95% CI 0.01 to 0.18; 1 study, 100 participants; moderate‐certainty evidence). The certainty of evidence was moderate due to risk of bias and was not downgraded for imprecision because the effect estimates and the CI did not cross the minimal clinically important difference line. Serious adverse events Compared to a non‐surgical programme, unilateral TKA may increase serious adverse events, but the evidence is very uncertain (RR 4.00, 95% CI 1.79 to 8.94; 1 study, 100 participants; very low‐certainty evidence). The certainty of evidence was very low given the imprecision of results, indirectness, and risk of bias. Withdrawals due to adverse events There may be no difference in withdrawals due to adverse events between unilateral TKA and non‐surgical treatment, but the evidence is very uncertain (n = 0 in both groups, Not estimable; 1 study, 100 participants; very low‐certainty evidence). The certainty of evidence was very low given the imprecision of results. Authors' conclusions Compared to a non‐surgical programme alone, TKA followed by a non‐surgical programme may reduce pain at a level that is clinically important; may improve physical function at a level that is not clinically important; and may reduce the need for follow‐up knee surgery. There is probably no clinically important difference in health‐related quality of life between TKA followed by a non‐surgical programme and a non‐surgical programme alone. TKA followed by a non‐surgical programme may increase the risk of serious adverse events, but the evidence is very uncertain. There may be no difference between groups in withdrawals due to adverse events, but the evidence is very uncertain. The conclusions of this study should be interpreted with caution due to several limitations: the evidence is based on a single study conducted in Denmark; TKA eligibility criteria used by surgeons were not clearly reported; 12% of adults had mild osteoarthritis; adults who reported severe pain in the previous week were excluded; and the included study employed a broad definition of serious adverse events. These factors may...
- 6 January 2026
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2026 (1) , CD015378
Total and partial knee arthroplasty versus non-surgical interventions of the knee for moderate to severe osteoarthritis
Rationale Total and partial knee arthroplasty (TKA, PKA) are common treatments for moderate to severe knee osteoarthritis. While effective in symptom management, these surgeries carry potential risks, necessitating careful evaluation of benefits and harms. High‐quality evidence comparing TKA/PKA to placebo, sham, or non‐surgical interventions is essential to support informed decision‐making. Objectives To assess the benefits and harms of TKA and PKA for people with moderate to severe knee osteoarthritis compared to placebo, sham (efficacy), or non‐surgical interventions for the knee (effectiveness). Search methods We searched CENTRAL, MEDLINE, Embase, and two trial registers from 2010 to January 2025. We also performed reference and citation checks. Two reviewers independently screened studies, extracted data, and assessed risk of bias and the certainty of evidence. Eligibility criteria We included randomised controlled trials of adults with moderate to severe osteoarthritis receiving TKA/PKA compared to placebo, sham, or non‐surgical treatments including physiotherapy, weight loss, pharmacotherapy, braces, insoles, and any intraarticular injection. We excluded studies including participants with other joint conditions or having TKA/PKA because of trauma (e.g. fracture), infection, or revision. Outcomes We reported on pain, physical function, knee surgery, patient satisfaction with treatment outcomes, health‐related quality of life, serious adverse events, and withdrawals due to adverse events. We measured outcomes at short‐term (≤ 6 months), intermediate‐term (6 to 12 months), and long‐term (≥ 1 year) follow‐up. Risk of bias We used the Cochrane RoB 1 tool to assess risk of bias. Synthesis methods We conducted a narrative synthesis, reported on risk ratios (RRs) for dichotomous data and mean differences (MDs) for continuous data with a 95% confidence interval (CI), and used GRADE to assess the certainty of evidence. Included studies One randomised controlled trial conducted in Denmark met the inclusion criteria. The study enrolled 100 adults with primary mild to severe knee osteoarthritis (Kellgren‐Lawrence score ≥ 2 to 4) and compared TKA followed by a non‐surgical programme (exercise, osteoarthritis education, dietary advice, insoles, pain medication) to the same non‐surgical programme alone. Synthesis of results Pain Compared to a non‐surgical programme, unilateral TKA may reduce pain at a level that is clinically important at one year (MD 17.60, 95% CI 8.25 to 26.95; 1 study, 100 participants; low‐certainty evidence). The certainty of evidence was low given the imprecision of results and risk of bias. Physical function Compared to a non‐surgical programme, unilateral TKA may improve physical function at one year, but the improvement might not be clinically important (MD 12.40, 95% CI 3.06 to 21.74; 1 study, 100 participants; low‐certainty evidence). The certainty of evidence was low given the imprecision of results and risk of bias. Knee surgery Compared to a non‐surgical programme, unilateral TKA may reduce the need for a follow‐up knee surgery (revision or subsequent knee surgery and initial knee surgery) at one year (RR 0.04, 95% CI 0.00 to 0.62; 1 study, 99 participants; low‐certainty evidence). The certainty of evidence was low given the imprecision of results and risk of bias. Patient satisfaction with treatment outcomes The included trial did not assess patient satisfaction with treatment outcomes. Health‐related quality of life There is probably no clinically important difference in health‐related quality of life between unilateral TKA and non‐surgical treatment at one year (MD 0.09, 95% CI 0.01 to 0.18; 1 study, 100 participants; moderate‐certainty evidence). The certainty of evidence was moderate due to risk of bias and was not downgraded for imprecision because the effect estimates and the CI did not cross the minimal clinically important difference line. Serious adverse events Compared to a non‐surgical programme, unilateral TKA may increase serious adverse events, but the evidence is very uncertain (RR 4.00, 95% CI 1.79 to 8.94; 1 study, 100 participants; very low‐certainty evidence). The certainty of evidence was very low given the imprecision of results, indirectness, and risk of bias. Withdrawals due to adverse events There may be no difference in withdrawals due to adverse events between unilateral TKA and non‐surgical treatment, but the evidence is very uncertain (n = 0 in both groups, Not estimable; 1 study, 100 participants; very low‐certainty evidence). The certainty of evidence was very low given the imprecision of results. Authors' conclusions Compared to a non‐surgical programme alone, TKA followed by a non‐surgical programme may reduce pain at a level that is clinically important; may improve physical function at a level that is not clinically important; and may reduce the need for follow‐up knee surgery. There is probably no clinically important difference in health‐related quality of life between TKA followed by a non‐surgical programme and a non‐surgical programme alone. TKA followed by a non‐surgical programme may increase the risk of serious adverse events, but the evidence is very uncertain. There may be no difference between groups in withdrawals due to adverse events, but the evidence is very uncertain. The conclusions of this study should be interpreted with caution due to several limitations: the evidence is based on a single study conducted in Denmark; TKA eligibility criteria used by surgeons were not clearly reported; 12% of adults had mild osteoarthritis; adults who reported severe pain in the previous week were excluded; and the included study employed a broad definition of serious adverse events. These factors may...
- Open Access
Protocol for the development of a core outcome set for the evaluation of shared decision-making interventions in healthcare
Introduction: Shared decision-making (SDM) is a process whereby patients are supported to reach decisions about their healthcare in collaboration with healthcare professionals. International policy and clinical guidelines highlight the ethical imperative of SDM and recommend SDM for many healthcare decisions and contexts. However, despite decades of SDM research, the impact of implementing SDM interventions within health care remains uncertain. High-quality health technology assessment (HTA) requires an understanding of how interventions to facilitate the adoption and implementation of SDM (e.g., through the use of patient decision aids, decision coaching, question prompt lists, training and feedback, or service changes) impact clinical and health service outcomes. Yet, synthesis of the existing literature is hindered by substantial heterogeneity in the evaluation of interventions to facilitate SDM. A core outcome set (COS) is an agreed standardised set of outcomes that should be measured and reported in all effectiveness studies. There is a COS for SDM in the context of rheumatology (rheuCOS-SDM), designed for use in research studies (e.g., clinical trials or observational studies) evaluating the impact of SDM interventions on clinical outcomes for patients. It is unclear, however, whether the outcome domains identified within a rheumatology context are relevant, comprehensive, or comprehensible when applied to a variety of SDM interventions tailored to and interacting with a range of patient populations, healthcare settings and contexts. The aim of this study is to develop a generic COS for evaluating the impact of SDM interventions on various outcomes. Outcomes for consideration may include assessments of the behaviours and experiences of patients, important others (e.g., carers or relatives) and health professionals, the dynamics within patient-professional interactions, health outcomes for individuals and for the wider population, and the cost-effectiveness of care. The broad scope of the COS will ensure its applicability and utility within diverse healthcare contexts and enable the synthesis of evidence to draw clear conclusions about the impact of SDM interventions, to influence healthcare policy. We define this new, comprehensive COS as the COS-SDM. Methods and Analysis: Through engagement with key interest holders (including patients and members of the public, clinicians and academics), we agreed on the scope of the COS and to adhere to the Core Outcome Measures in Effectiveness Trials (COMET) handbook and Core Outcome Set-STAndards for Development (COS-STAD) guidelines. This will involve production of a ‘long’ (comprehensive) list of candidate outcome domains (using evidence synthesis, a COS developed in the context of Rheumatology, and qualitative interviews with interest holders internationally), prioritisation of a ‘short’ (refined) list of core outcome domains (utilising a sequential two-round international online Delphi), and reaching consensus on the final outcome set (through international meetings, applying modified nominal group techniques and predefined criteria for agreement). Ethics and Dissemination: Research ethics approval has been granted in the UK (University of Bristol Faculty Ethics Committee, ref: 7741; University of Exeter Faculty Ethics Committee, ref: 8207624). The final COS will be disseminated by presentation at international conferences and publication in a peer-reviewed journal. Further dissemination is planned through our patient/public advisory group, professional networks, and executive group channels, to publicise the COS to patient groups, funders, journal editors, international regulatory bodies and HTA boards. Registration: This project has been registered in the COMET database ( www.comet-initiative.org/Studies/Details/3586 ).
Open AccessProtocol for the development of a core outcome set for the evaluation of shared decision-making interventions in healthcare
Introduction: Shared decision-making (SDM) is a process whereby patients are supported to reach decisions about their healthcare in collaboration with healthcare professionals. International policy and clinical guidelines highlight the ethical imperative of SDM and recommend SDM for many healthcare decisions and contexts. However, despite decades of SDM research, the impact of implementing SDM interventions within health care remains uncertain. High-quality health technology assessment (HTA) requires an understanding of how interventions to facilitate the adoption and implementation of SDM (e.g., through the use of patient decision aids, decision coaching, question prompt lists, training and feedback, or service changes) impact clinical and health service outcomes. Yet, synthesis of the existing literature is hindered by substantial heterogeneity in the evaluation of interventions to facilitate SDM. A core outcome set (COS) is an agreed standardised set of outcomes that should be measured and reported in all effectiveness studies. There is a COS for SDM in the context of rheumatology (rheuCOS-SDM), designed for use in research studies (e.g., clinical trials or observational studies) evaluating the impact of SDM interventions on clinical outcomes for patients. It is unclear, however, whether the outcome domains identified within a rheumatology context are relevant, comprehensive, or comprehensible when applied to a variety of SDM interventions tailored to and interacting with a range of patient populations, healthcare settings and contexts. The aim of this study is to develop a generic COS for evaluating the impact of SDM interventions on various outcomes. Outcomes for consideration may include assessments of the behaviours and experiences of patients, important others (e.g., carers or relatives) and health professionals, the dynamics within patient-professional interactions, health outcomes for individuals and for the wider population, and the cost-effectiveness of care. The broad scope of the COS will ensure its applicability and utility within diverse healthcare contexts and enable the synthesis of evidence to draw clear conclusions about the impact of SDM interventions, to influence healthcare policy. We define this new, comprehensive COS as the COS-SDM. Methods and Analysis: Through engagement with key interest holders (including patients and members of the public, clinicians and academics), we agreed on the scope of the COS and to adhere to the Core Outcome Measures in Effectiveness Trials (COMET) handbook and Core Outcome Set-STAndards for Development (COS-STAD) guidelines. This will involve production of a ‘long’ (comprehensive) list of candidate outcome domains (using evidence synthesis, a COS developed in the context of Rheumatology, and qualitative interviews with interest holders internationally), prioritisation of a ‘short’ (refined) list of core outcome domains (utilising a sequential two-round international online Delphi), and reaching consensus on the final outcome set (through international meetings, applying modified nominal group techniques and predefined criteria for agreement). Ethics and Dissemination: Research ethics approval has been granted in the UK (University of Bristol Faculty Ethics Committee, ref: 7741; University of Exeter Faculty Ethics Committee, ref: 8207624). The final COS will be disseminated by presentation at international conferences and publication in a peer-reviewed journal. Further dissemination is planned through our patient/public advisory group, professional networks, and executive group channels, to publicise the COS to patient groups, funders, journal editors, international regulatory bodies and HTA boards. Registration: This project has been registered in the COMET database ( www.comet-initiative.org/Studies/Details/3586 ).
- Open Access
- 9 August 2024
- Published by Wiley in Musculoskeletal Care
- Vol. 22 (3) , e1927
Determining Appropriateness of Total Joint Arthroplasty for Hip and Knee Osteoarthritis: A Patient‐Centred Conceptual Model
Introduction: Total joint arthroplasty (TJA) for osteoarthritis is one of several treatment options with benefits and harms that patients value differently. However, the process for determining TJA appropriateness does not sufficiently acknowledge patient perspectives. The aim of this paper is to propose an evidence‐informed patient‐centred conceptual model for elective TJA appropriateness for hip and knee osteoarthritis.Methods: Our interprofessional team developed a conceptual model for determining the appropriateness of adults considering elective TJA. The model was informed by a review of the evidence, a qualitative study we conducted with adults who underwent TJA for osteoarthritis to determine barriers and facilitators to the use of appropriateness criteria, and the research and clinical experience of team members.Results: Appropriateness is providing health services (e.g., TJA) with net benefits to the right patient at the right time. The proposed Patient‐centred Elective TJA Appropriateness Conceptual Model involves three key steps. First, assess adults with osteoarthritis to determine eligibility for TJA. Second, acknowledge the patient's informed preferences including their expectations and goals. Third, explore and support their mental and physical readiness for TJA. Given that osteoarthritis is a chronic condition, these steps can be revisited over time with patients.Discussion and Conclusion: Our proposed conceptual model reconceptualises the appropriateness of TJA to be more patient‐centred. Hence, this approach has the potential to be a more inclusive approach and ensure patients undergoing TJA are eligible, ready to proceed, and achieve what matters most to them. Future research is needed to test and validate the model.
- 9 August 2024
- Published by Wiley in Musculoskeletal Care
- Vol. 22 (3) , e1927
Open AccessDetermining Appropriateness of Total Joint Arthroplasty for Hip and Knee Osteoarthritis: A Patient‐Centred Conceptual Model
Introduction: Total joint arthroplasty (TJA) for osteoarthritis is one of several treatment options with benefits and harms that patients value differently. However, the process for determining TJA appropriateness does not sufficiently acknowledge patient perspectives. The aim of this paper is to propose an evidence‐informed patient‐centred conceptual model for elective TJA appropriateness for hip and knee osteoarthritis.Methods: Our interprofessional team developed a conceptual model for determining the appropriateness of adults considering elective TJA. The model was informed by a review of the evidence, a qualitative study we conducted with adults who underwent TJA for osteoarthritis to determine barriers and facilitators to the use of appropriateness criteria, and the research and clinical experience of team members.Results: Appropriateness is providing health services (e.g., TJA) with net benefits to the right patient at the right time. The proposed Patient‐centred Elective TJA Appropriateness Conceptual Model involves three key steps. First, assess adults with osteoarthritis to determine eligibility for TJA. Second, acknowledge the patient's informed preferences including their expectations and goals. Third, explore and support their mental and physical readiness for TJA. Given that osteoarthritis is a chronic condition, these steps can be revisited over time with patients.Discussion and Conclusion: Our proposed conceptual model reconceptualises the appropriateness of TJA to be more patient‐centred. Hence, this approach has the potential to be a more inclusive approach and ensure patients undergoing TJA are eligible, ready to proceed, and achieve what matters most to them. Future research is needed to test and validate the model.
- Open Access
- 18 January 2024
- Published by Oxford University Press (OUP) in Journal of Hip Preservation Surgery
- Vol. 11 (2) , 118-124
The relationship of pain catastrophizing with postoperative patient-reported outcome measures in adults with pre-arthritic hip disease
The association between preoperative pain catastrophizing and postoperative patient-reported outcome measures of patients with pre-arthritic hip disease was evaluated. All patients scheduled for joint-preserving surgeries of the hip (JPSH) at our institution were approached. Patient demographics (age, sex, body mass index (BMI)), pain intensity (Numeric Pain Scale (NPS)) and pain catastrophizing (Pain Catastrophizing Scale (PCS)) were collected preoperatively. Patient function (12-Item International Hip Outcome Tool (iHot-12)) and physical and mental health (Patient-Reported Outcomes Measurement Information System (PROMIS-10) mental/physical) were collected preoperatively, three-month and one-year postoperatively. The analysis consisted of multivariate linear regression models fitted for continuous scores of outcome measures at three-month and one-year. Correlation between preoperative PCS and iHot-12 was assessed using the Pearson correlation coefficient. A total of 274 patients completed the PCS and were included in the multivariate linear regression models. Most patients were females (66.8%), mean age was 33 (SD 9), mean BMI was 26.5 (SD 5.8) and most were diagnosed with femoro-acetabular impingement (46.0%) and underwent arthroscopy (77.0%). There were statistically significant correlations between PCS and iHot-12 (preoperatively −0.615, P < 0.001; three-month −0.242, P = 0.002). Statistically significant associations were found for function (three-month PCS P = 0.046, age P = 0.014, NPS P = 0.043; one-year BMI P = 0.005, NPS P = 0.014), physical health (three-month BMI, P = 0.002, NPS P = 0.008; one-year BMI P = 0.002, NPS P = 0.013) and mental health (three-month BMI P = 0.047; one-year BMI P = 0.030). There is an association between function and preoperative pain catastrophizing in patients with pre-arthritic hip disease undergoing JPSH. When considering confounding variables, preoperative pain catastrophizing is associated with short-term recovery.
- 18 January 2024
- Published by Oxford University Press (OUP) in Journal of Hip Preservation Surgery
- Vol. 11 (2) , 118-124
Open AccessThe relationship of pain catastrophizing with postoperative patient-reported outcome measures in adults with pre-arthritic hip disease
The association between preoperative pain catastrophizing and postoperative patient-reported outcome measures of patients with pre-arthritic hip disease was evaluated. All patients scheduled for joint-preserving surgeries of the hip (JPSH) at our institution were approached. Patient demographics (age, sex, body mass index (BMI)), pain intensity (Numeric Pain Scale (NPS)) and pain catastrophizing (Pain Catastrophizing Scale (PCS)) were collected preoperatively. Patient function (12-Item International Hip Outcome Tool (iHot-12)) and physical and mental health (Patient-Reported Outcomes Measurement Information System (PROMIS-10) mental/physical) were collected preoperatively, three-month and one-year postoperatively. The analysis consisted of multivariate linear regression models fitted for continuous scores of outcome measures at three-month and one-year. Correlation between preoperative PCS and iHot-12 was assessed using the Pearson correlation coefficient. A total of 274 patients completed the PCS and were included in the multivariate linear regression models. Most patients were females (66.8%), mean age was 33 (SD 9), mean BMI was 26.5 (SD 5.8) and most were diagnosed with femoro-acetabular impingement (46.0%) and underwent arthroscopy (77.0%). There were statistically significant correlations between PCS and iHot-12 (preoperatively −0.615, P < 0.001; three-month −0.242, P = 0.002). Statistically significant associations were found for function (three-month PCS P = 0.046, age P = 0.014, NPS P = 0.043; one-year BMI P = 0.005, NPS P = 0.014), physical health (three-month BMI, P = 0.002, NPS P = 0.008; one-year BMI P = 0.002, NPS P = 0.013) and mental health (three-month BMI P = 0.047; one-year BMI P = 0.030). There is an association between function and preoperative pain catastrophizing in patients with pre-arthritic hip disease undergoing JPSH. When considering confounding variables, preoperative pain catastrophizing is associated with short-term recovery.
- 6 July 2023
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 29 (6) , 942-954
Exploring appropriateness criteria for informing the total knee arthroplasty decision‐making process: An interpretive descriptive study
RationalThe Hawker appropriateness criteria for total knee arthroplasty (TKA) are: osteoarthritis symptoms impacting quality of life, evidence of osteoarthritis, trial of conservative treatments, patient's realistic expectations, patient/surgeon agree benefits outweigh risks, and readiness for surgery. Little is known about the barriers and facilitators of using the Hawker et al. appropriateness criteria for TKA in clinical practice. Aims and ObjectivesExplore the barriers and facilitators to using appropriateness criteria for TKA in making decisions for adults with knee osteoarthritis. MethodsInterpretive descriptive qualitative study at an academic hospital. Purposive sampling aimed to recruit: (1) healthcare team members at all levels influencing care delivery, and (2) adults with TKA assessed at the hospital clinic. Semi-structured interviews asked about the barriers/facilitators to using the Hawker appropriateness criteria. Data analysis consisted of inductive thematic analysis with themes mapped to the Consolidated Framework for Implementation Research domains. ResultsNine healthcare professionals and 14 adults with TKA participated and identified common barriers to using the Hawker appropriateness criteria: (a) intervention characteristics domain: difficulty to assess criteria, patients expecting healthcare professionals to decide, limited accessibility to conservative treatments; (b) individuals characteristics domain: no need to change current TKA process, clinical judgement limited to OA severity/age, implicit assessment of subjective criteria; (c) inner setting domain: TKA information received after decision made; and (d) outer setting domain: no timely access to TKA. A facilitator of use was evidence/buy-in fosters programme changes. ConclusionBarriers to using the criteria relevant to clinical practice and the healthcare system were identified while only one facilitator was revealed. Interventions tailored to these barriers are needed to support the use of the Hawker appropriateness criteria in TKA decision-making.
- 6 July 2023
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 29 (6) , 942-954
Exploring appropriateness criteria for informing the total knee arthroplasty decision‐making process: An interpretive descriptive study
RationalThe Hawker appropriateness criteria for total knee arthroplasty (TKA) are: osteoarthritis symptoms impacting quality of life, evidence of osteoarthritis, trial of conservative treatments, patient's realistic expectations, patient/surgeon agree benefits outweigh risks, and readiness for surgery. Little is known about the barriers and facilitators of using the Hawker et al. appropriateness criteria for TKA in clinical practice. Aims and ObjectivesExplore the barriers and facilitators to using appropriateness criteria for TKA in making decisions for adults with knee osteoarthritis. MethodsInterpretive descriptive qualitative study at an academic hospital. Purposive sampling aimed to recruit: (1) healthcare team members at all levels influencing care delivery, and (2) adults with TKA assessed at the hospital clinic. Semi-structured interviews asked about the barriers/facilitators to using the Hawker appropriateness criteria. Data analysis consisted of inductive thematic analysis with themes mapped to the Consolidated Framework for Implementation Research domains. ResultsNine healthcare professionals and 14 adults with TKA participated and identified common barriers to using the Hawker appropriateness criteria: (a) intervention characteristics domain: difficulty to assess criteria, patients expecting healthcare professionals to decide, limited accessibility to conservative treatments; (b) individuals characteristics domain: no need to change current TKA process, clinical judgement limited to OA severity/age, implicit assessment of subjective criteria; (c) inner setting domain: TKA information received after decision made; and (d) outer setting domain: no timely access to TKA. A facilitator of use was evidence/buy-in fosters programme changes. ConclusionBarriers to using the criteria relevant to clinical practice and the healthcare system were identified while only one facilitator was revealed. Interventions tailored to these barriers are needed to support the use of the Hawker appropriateness criteria in TKA decision-making.
- 8 June 2023
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2023 (6)
Total and partial knee arthroplasty versus non-surgical interventions of the knee for moderate to severe osteoarthritis
- 8 June 2023
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2023 (6)
Total and partial knee arthroplasty versus non-surgical interventions of the knee for moderate to severe osteoarthritis
- 3 May 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (7) , 999-1000
Response to commentary on ‘Instruments to assess appropriateness of hip and knee arthroplasty: a systematic review’
- 3 May 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (7) , 999-1000
Response to commentary on ‘Instruments to assess appropriateness of hip and knee arthroplasty: a systematic review’
- 9 March 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (7) , 847-864
Instruments to assess appropriateness of hip and knee arthroplasty: a systematic review
- 9 March 2023
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 31 (7) , 847-864
Instruments to assess appropriateness of hip and knee arthroplasty: a systematic review